Department of Neurology, Beijing Tiantan Hospital China National Clinical Research Center for Neurological Diseases Advanced Innovation Center for Human Brain Protection The Capital Medical University Beijing China.
The Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides of Ministry of Health Beijing Key Laboratory of Cardiovascular Receptors Research Peking University Beijing China.
J Am Heart Assoc. 2021 Dec 7;10(23):e020979. doi: 10.1161/JAHA.121.020979. Epub 2021 Nov 24.
Background Trimethyllysine, a trimethylamine N-oxide precursor, has been identified as an independent cardiovascular risk factor in acute coronary syndrome. However, limited data are available to examine the role of trimethyllysine in the population with stroke. We aimed to examine the relationship between plasma trimethyllysine levels and stroke outcomes in patients presenting with ischemic stroke or transient ischemic attack. Methods and Results Data of 10 027 patients with ischemic stroke/transient ischemic attack from the CNSR-III (Third China National Stroke Registry) and 1-year follow-up data for stroke outcomes were analyzed. Plasma levels of trimethyllysine were measured with mass spectrometry. The association between trimethyllysine and stroke outcomes was analyzed using Cox regression models. Mediation analysis was performed to examine the mediation effects of risk factors on the associations of trimethyllysine and stroke outcomes. Elevated trimethyllysine levels were associated with increased risk of cardiovascular death (quartile 4 versus quartile 1: adjusted hazard ratio [HR], 1.72; 95% CI, 1.03-2.86) and all-cause mortality (quartile 4 versus quartile 1: HR, 1.97; 95% CI, 1.40-2.78) in multivariate Cox regression model. However, no associations were found between trimethyllysine and nonfatal stroke recurrence or nonfatal myocardial infarction. Trimethyllysine was associated with cardiovascular death independent of trimethylamine N-oxide. Both estimated glomerular filtration rate and hs-CRP (high-sensitivity C-reactive protein) had significant mediation effects on the association of trimethyllysine with cardiovascular death, with a mediation effect of 37.8% and 13.4%, respectively. Conclusions Elevated trimethyllysine level is associated with cardiovascular death among patients with ischemic stroke/transient ischemic attack. Mediation analyses propose that trimethyllysine contributes to cardiovascular death through inflammation and renal function, suggesting a possible pathomechanistic link.
三甲胺 N-氧化物前体三甲赖氨酸已被确定为急性冠状动脉综合征的独立心血管风险因素。然而,目前关于其在中风人群中的作用的数据有限。我们旨在研究缺血性卒中和短暂性脑缺血发作患者的血浆三甲赖氨酸水平与卒中结局之间的关系。
对 CNSR-III(第三次中国国家卒中登记研究)中的 10027 例缺血性卒中和短暂性脑缺血发作患者的数据和 1 年卒中结局随访数据进行了分析。采用质谱法测定血浆三甲赖氨酸水平。采用 Cox 回归模型分析三甲赖氨酸与卒中结局之间的关系。采用中介分析检验风险因素对三甲赖氨酸与卒中结局关联的中介作用。
在多变量 Cox 回归模型中,较高的三甲赖氨酸水平与心血管死亡风险增加相关(四分位 4 与四分位 1:调整后的危险比[HR],1.72;95%CI,1.03-2.86)和全因死亡率(四分位 4 与四分位 1:HR,1.97;95%CI,1.40-2.78)。然而,三甲赖氨酸与非致死性卒中复发或非致死性心肌梗死之间没有关联。三甲赖氨酸与心血管死亡相关,独立于三甲胺 N-氧化物。估计肾小球滤过率和 hs-CRP(高敏 C 反应蛋白)对三甲赖氨酸与心血管死亡的关联均有显著的中介作用,分别为 37.8%和 13.4%。
缺血性卒中和短暂性脑缺血发作患者中,较高的三甲赖氨酸水平与心血管死亡相关。中介分析表明,三甲赖氨酸通过炎症和肾功能导致心血管死亡,提示可能存在一种发病机制联系。